MDR_REPORT_KEY|MDR_TEXT_KEY|TEXT_TYPE_CODE|PATIENT_SEQUENCE_NUMBER|DATE_REPORT|FOI_TEXT|BRAND_NAME|CATALOG_NUMBER|DATE_RECEIVED|DATE_REMOVED_FLAG|DATE_RETURNED_TO_MANUFACTURER|DEVICE_AGE_TEXT|DEVICE_AVAILABILITY|DEVICE_EVALUATED_BY_MANUFACTUR|DEVICE_EVENT_KEY|DEVICE_OPERATOR|DEVICE_REPORT_PRODUCT_CODE|DEVICE_SEQUENCE_NO|EXPIRATION_DATE_OF_DEVICE|GENERIC_NAME|IMPLANT_FLAG|LOT_NUMBER|MANUFACTURER_D_ADDRESS_1|MANUFACTURER_D_ADDRESS_2|MANUFACTURER_D_CITY|MANUFACTURER_D_COUNTRY_CODE|MANUFACTURER_D_NAME|MANUFACTURER_D_POSTAL_CODE|MANUFACTURER_D_STATE_CODE|MANUFACTURER_D_ZIP_CODE|MANUFACTURER_D_ZIP_CODE_EXT|MODEL_NUMBER|OTHER_ID_NUMBER|filter
6233845|64197775|N|1||EVENTS LYMPHOMA CAPSULAR CONTRACTURE EDEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|UNK STYLE 110|01/09/2017|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247187|64666746|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX115-290|01/12/2017|||DA|N|R||0HP|FTR|1.0|09/04/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1321464|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6257136|64954239|N|1||DEVICE HISTORY RECORD DHR IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|STYLE 150 EXPANDABLE BREAST IMPLANT|N-27-150386|01/17/2017||||N|R||0HP|FTR|1.0|03/26/2017|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2262674|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247063|64661472|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|01/12/2017||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6247063|64661472|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSLP280|01/12/2017|||DA|*|*||0HP|FTR|1.0|05/27/2015|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1845063|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247160|64710080|N|1||B6 -WEIGHT FLUCTUATIONS EVENTS WEIGHT LOSS ANEMIA CAPSULAR CONTRACTURE LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6247152|64673720|N|1||B4 EVENTS WEIGHT LOSS ANEMIA CAPSULAR CONTRACTURE LYMPHADENOPATHY LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120601|01/12/2017||01/26/2017|DA|R|Y||0HP|FTR|1.0|04/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||146123|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
1060667|868720|D|1||DEVELOPED FIBROMYALGIA RARE FORM CANTANIOUS T-CELL LYMPHOMA CALLED LYMPHOMATOID PAPULOSIS MAMMOGRAM RUPTURED 20 YR OLD  SILICONE BREAST IMPLANT RARE FORM LYMPHOMA AFFECTS ONE PERSON 12-19 MILLION POPULATION SPOKEN 5 WOMEN DEVELOPED RARE LYMPHOMA SILICONE IMPLANTS RUPTURED MET WOMEN SUPPORT GROUP RARE CANCER 800 KNOWN CASES WORLD MAKES TRUE POSSIBLE RISK SILICONE LARGE DEEP SKIN LESIONS BODY LESIONS INTERNALLY WELL DOW CORNING 400CC ROUND BREAST IMPLANT IMPLANTED 1974 PTS IMPLANT RUPTURED 1993 MAMMOGRAM CHECK INTEGRITY DEVELOPED RARE CANTANIOUS T-CELL LYMPHOMA CALLED LYMPHOMATOID PAPULOSIS WITHIN WEEKS IMPLANT RUPTURED FINALLY FOUND DOCTOR REMOVE RUPTURED IMPLANT 1998 SURGEON REMOVE LOOSE SILICONE GEL GLOVED HANDS UNABLE REMOVE SILICONE MAY PROBLEMS INCLUDING FIBROMYALGIA RAYNAUDIS DIGESTIVE METABOLIC SLEEP SEIZURES NEUROLOGICAL PROBLEMS COMPLETELY DISABLED ABLE WORK SINCE 1994 CONTINUING GET WORSE TAKE WEEKLY CHEMO THERAPY METHOTREXATE PAST 10 YEARS CONTROL MANY SEVERE SKIN LESIONS GET BODY INSIDE DIAGNOSIS REASON USE LEFT BREAST DEVELOP- GIVE NORMAL EVENT ABATED USE STOPPED|DOW CORNING|*|06/12/2008|V|||Y||1029822.0|0HP|FTR|1.0||SILICONE BREAST IMPLANT|Y|*|*||*|*|DOW CORNING CORPRATION|||||*|*|True
2338306|2365004|D|1||REPORT LYMPHOMA BREAST CAPSULE SILICONE IMPLANT-RECONSTRUCTED PT PUBLISHED AMERICAN SURGEON SEPT 2010 VOL 76 PG 1030-31 REVIEWED ADDL INFO REQUESTED AUTHOR AUTHOR RESPONDED DATE WITHIN ARTICLE AUTHOR NOTES B6 WOMAN TISSUE DIAGNOSIS ADENOCARCINOMA LEFT BREAST UNDERWENT LEFT MODIFIED RADICAL MASTECTOMY PROPHYLACTIC RIGHT BREAST SIMPLE MASTECTOMY 1999 IMMEDIATELY FOLLOWED PRIMARY RECONSTRUCTION SILICONE IMPLANTS LYMPH NODE BASIN FREE DISEASE PT RECEIVED CHEMOTHERAPY RADIATION THERAPY SIX YEARS LATER PRESENTED PRIMARY CARE LUMP RECONSTRUCTED RIGHT BREAST EXAMINATION 3CM NON-TENDER MOBILE CYSTIC MASS RIGHT BREAST 9 OCLOCK POSITION COMPRESSION IMPLANT CAUSED ENLARGEMENT LESION REPORT NIPPLE DISCHARGE RETRACTION SKIN AREOLA COMPLEX NORMAL PALPABLE LYMPH NODES PRIMARY CARE PHYSICIAN PERFORMED NEEDLE ASPIRATION MASS ORANGE COLOR CYTOLOGIC FEATURES ADENOCARCINOMA UNDERWENT BILATERAL IMPLANT REMOVAL EXCISION CYSTIC MASS BIOPSIES CAPSULES LEFT BREAST IMPLANT INTACT CAPSULE NORMAL APPEARANCE RIGHT BREAST IMPLANT INTACT WELL HOWEVER ANTERIOR POSTERIOR WALLS CAPSULE COATED NECROTIC HETEROGENEOUS MATERIAL INITIAL BIOPSIES RIGHT BREAST CAPSULE SHOWED POORLY DIFFERENTIATED ADENENOCARCINOMA IMMUNOPOSITIVE CD30 EMA T-CELL MARKERS CD45RO CD43 FINAL PATHOLOGY MASS REVIEW SECOND PATHOLOGIST UNIVERSITY HOSPITAL ANAPLASTIC LARGE CELL LYMPHOMA ALK- CELL PHENOTYPE POST OP RECOVER UNEVENTFUL PT COURSE CHOP PROTOCOL PTS LYMPHOMA DISCOVERED CYSTIC LESION INVOLVING RIGHT BREAST CAPSULE PRELIMINARY CYTOLOGIC FEATURE LESION POORLY DIFFERENTIATED ADENENOCARCINOMA SIMILAR PRIOR DIAGNOSIS LEFT BREASTONLY IMMUNOHISTOCHEMISTRY SPECIMEN CORRECTLY DIAGNOSED ALCL T-CELL LYMPHOMA TREATED CHOP CHEMOTHERAPY PROTOCOL|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/09/2011|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
2163717|2109276|D|1||MEDWATCH REPORT RECEIVED B4 2011 B4 HEALTHCARE PROFESSIONAL REPORTING FOLLOWING NON HODGKINS LYMPHOMA FELT CAUSED SILICONE BREAST IMPLANT PLACED 2003 CALLED OFFICE SPOKE MEDICAL STAFF REPORTS DEVICE REMOVED B6 2011 DOCTOR BELIEVES SALINE BREAST IMPLANT PROBABLE CAUSE LEAD LYMPHOMA UNKNOWN DEVICE AVAILABLE RETURN SEVERAL ATTEMPTS OBTAIN INFORMATION OFFICE PATIENTS OPERATIVE REPORT PROGRESS NOTES PATIENT HISTORY RECEIVED VIA FAX DIAGNOSIS ANAPLASTIC LARGE T-CELL LYMPHOMA MADE ASPIRATES NOTE ALK-STATUS B6 2011 UNDERWENT FIRST CYCLE CHOP ACCORDING NOTES DATED B6 2011 COMPLETED 3 CYCLES CHOP TREATMENT B6 2011 LEFT BREAST EXPLORATION IMPLANT REMOVAL ADDITION LARGE MATTED AXILLARY NODE SAMPLED RIGHT BREAST IMPLANT REMOVED EARLIER PROCEDURE ACCORDING CONVERSATION OFFICE HOWEVER DAY SURGERY UNKNOWN PATHOLOGY REPORT REQUESTED YET RECEIVED PATIENT SCHEDULED STEM CELL TRANSPLANT RADIATION TREATMENT PATIENT WELL TIME|STYLE 168 SALINE FILLED BREAST IMPLANT|168-330|06/28/2011|||DA|N|R||0HP|FWM|1.0|02/27/2007|nan||560018|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
2722372|2989693|D|1||ANAPLASTIC LARGE T-CELL LYMPHOMA ASSOCIATED SALINE-TYPE BREAST IMPLANT 2 YEAR HISTORY RECURRENT EFFUSION SURROUNDING PROTHESIS REMOVAL LYMPHOMA CELLS CONFINED FIBRINOUS EFFUSION WITHOUT MEASUREABLE MASS IMPLANT CAPSULE SOFT TISSUE INVASION LYMPHADENOPATHY PROGNOSIS FAVORABLE DATES USE 2 YEARS REASON USE RECURRENT BREAST ABSCESS|MCGHAN||08/27/2012||||Y|||0HP|FTR|1.0||SALINE BREAST PROSTHESIS, 560 CC|||||||MCGHAN|||||||True
3030978|54657878|D|1||RESEARCH REVIEW RN PRODUCT SUPPORT SPECIALIST FOLLOWING ARTICLE CAME ATTENTION SEROMA-ASSOCIATED PRIMARY ANAPLASTIC LARGE-CELL LYMPHOMA ADJACENT BREAST IMPLANTS INDOLENT T-CELL LYMPHOMA PROLIFERATIVE DISORDER ANJA RODEN ET AL MODERN PATHOLOGY 2008 21 455-463 WITHIN ARTICLE AUTHOR PRESENTS 4 PATIENTS PRIMARY ANAPLASTIC LARGE-CELL LYMPHOMA BREAST ASSOCIATED BREAST IMPLANT SEROMA|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|11/20/2012|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||GOLETA|US|UNK||CA|||||True
3516781|15024064|D|1||LEGAL DOCUMENTS RECEIVED ALLERGAN NOTE CASE LYMPHOMA DOCUMENTS STATE B6 2002 PATIENT IMPLANTED MCGHAN 468 IMPLANTS B62011 PATIENT DIAGNOSED ABNORMAL T-CELL LARGE SIZE CONSISTENT T-CELL LYMPHOMA PARTICULARLY ALCL RADIOLOGY SCHEDULING FORM PREPARED EMORY HEALTHCARE B6 2011 DESCRIBES DIAGNOSIS T-CELL LYMPHOMA BREAST IMPLANTS TIME INVESTIGATION CANNOT TAKE PLACE DUE LACK INFORMATION PROVIDED ADDITIONAL INFORMATION OBTAINED REVIEWED REPORTED|STYLE 468 SALINE FILLED BREAST IMPLANT|468-495|11/22/2013|||DA|N|R||0HP|FWM|0.0||nan||NI|||GOLETA, NE||ALLERGAN||CA|||||True
3883642|4565748|D|1||ADDITIONAL INFO RECEIVED LITERATURE ARTICLE ANAPLASTIC LARGE CELL LYMPHOMA BREAST IMPLANTS FIVE AUSTRALIAN CASES PUBLISHED PLASTIC RECONSTRUCTIVE SURGERY B6 2012 PG 610E-617E WITHIN ARTICLE AUTHOR DESCRIBES B6 UNDERWENT BILATERAL AUGMENTATION 110-360 INAMED TEXTURED ROUND DEVICES VIA INFRAMAMMARY SUB GLANDULAR POCKET B6 2008 PT PRESENTED SPONTANEOUS LEFT BREAST SWELLING ALTHOUGH FEVER MILD DISCOMFORT LEFT BREAST DIFFUSELY SWOLLEN PT NORMAL MAMMO 2008 2009 ULTRASOUND REVEALED SEROMA CT SCAN SHOWED INFOLDING IMPLANT 7 9 OCLOCK APPARENT MASS SLIGHTLY INCREASED DENSITY B6 2009 SURGERY PLANNED REMOVE PRESUMED RUPTURED IMPLANT TIME SURGERY STRAW COLORED SEROMA 200CC FOUND IMPLANT INTACT WITHIN CAPSULE TWO AREAS GRANULOMATOUS TISSUE THICK MASS INFEROMEDIALLY CAPSULE MASS SENT MICROBIOLOGY CULTURE HISTOPATHOLOGY LYMPHOID CELLS HIGHLY ATYPICAL SHOWING ENLARGED IRREGULARLY CONFIGURED NUCLEI IMMUNOHISTOCHEMICAL ANALYSIS SHOWED CD30 + ALK- B-CELL MARKER NEGATIVE T-CELL MARKER PARTIAL PATCHILY-POSITIVE CD3 CD43 CD45RO CD5 TISSUE FINDINGS CONSISTENT LOCALIZED FORM SYSTEMIC ALCL LARGE T-CELL LYMPHOMA BREAST HEALED RECURRENT MASS APPEARED WEEKS LATER STAGING CT CHEST ABD PELVIS PET SCAN SHOWED EVIDENCE DISEASE OUTSIDE BREAST UNDERWENT CHEMO CYCLOPHOSPHAMIDE DOXORUBICIN VINCRISTINE PREDNISONE B6 2009 MASS FAILED RESPOND PROGRESSED WOUND LYMPHOMA METASTASIZED THORACOLUMBAR REGION RIGHT LUNG SEEN B6 2009 PET SCAN TREATED RADIATION SECOND ROUND CHEMO USING GEMCITABINE IFOSFAMIDE VINORELBINE RESPONDED WELL UNDERWENT BONE MARROW TRANSPLANT 122009 TWO YEARS DIAGNOSIS REMAINS REMISSION EVENT ORIGINALLY SUBMITTED VIA B4 B4 2011|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110361|06/18/2014|||DA|N|R||0HP|FTR|1.0|09/30/2010|nan||1148082|||ARKLOW, COUNTY, WICKLOW|EI|ALLERGAN|||||||True
3642249|17838426|D|1||EVENT ANAPLASTIC LARGE CELL LYMPHOMA REPORTED JOURNAL ARTICLE PRIMARY SECONDARY T-CELL LYMPHOMAS BREAST GABRIELA ET AL APPL IMMUNOHISTOCHEM MOL MORPHOL VOLUME 17 NUMBER 4 JULY 2009 ALTHOUGH MFR DEVICE UNK ALLERGANS APPROACH COMPLIANCE RESOLVE DOUBT FAVOR REPORTING|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|02/05/2014|||DA|N|R||0HP|FTR|1.0||nan||NI|||GOLETA|US|ALLERGAN||CA|||||True
4838209|20777628|D|1||DIAGNOSIS T-CELL LYMPHOMA ANAPLASTIC REFRACTORY CHEMOTHERAPY|UNKNOWN BREAST IMPLANT||06/05/2015|||||||0|FWM|1.0||NONE|||||||nan|||||||True
5067426|25380332|N|1||B4 DEVICE LABELING ADDRESSES ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING MAY OCCUR ANDOR PERSIST VARYING INTENSITY ANDOR VARYING LENGTH TIME PAIN HEMATOMASEROMA CHANGES NIPPLE BREAST SENSATION IMPLANT EXTRUSION NECROSIS DELAYED WOUND HEALING BREAST TISSUE ATROPHYCHEST WALL DEFORMITY CALCIUM DEPOSITS FORM TISSUE CAPSULE SURROUNDING IMPLANT SYMPTOMS MAY INCLUDE PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS LYMPHOMAS INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE 20 CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED IDENTIFY ALCL CANCERS BREAST IMPORTANT NOTE FINDINGS CONSIDERED PRELIMINARY MAJORITY CASES REPORTED PATIENTS BREAST IMPLANTS PRESENT LATE OCCURRING SEROMAS INDOLENT CLINICAL COURSE INCLUDING INVOLVING SPONTANEOUS REMISSION WITHOUT ADJUVANT THERAPY STUDY CONCLUDED CAUSE EFFECT RELATIONSHIP ALCL BREAST IMPLANTS PERTINENT FINDINGS RESPECTING CASES ASSOCIATED ALLERGAN DEVICES REPORTED ALLERGAN EG TIME CLINICAL PRESENTATION SIGNS SYMPTOMS IMMUNOHISTOLOGICAL ANALYSIS TYPE IMPLANT TEXTURE PATIENT HISTORY IMPLANTS PHYSICIANS KEEP ABREAST ALCL LITERATURE PROVIDE APPROPRIATE THERAPY PATIENTS NEEDED|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MM120-280|09/10/2015||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4742777|16542156|D|1||JOURNAL ARTICLE ANAPLASTIC LARGE-CELL LYMPHOMA WOMEN BREAST IMPLANTS DEJONG ET ALB6 2008 JOURNAL AMERICAN MEDICAL ASSOCIATION REPORTS ANAPLASTIC LARGE T-CELL LYMPHOMA DIAGNOSED RIGHT SIDE STAGE IV REPORT DEVICE TEXTURED SILICONE MCGHAN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/30/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA||NE|CS|ALLERGAN|||||||True
5286954|40348295|N|1||MEDWATCH SENT FDA 3142016 PHYSICIAN CONFIRM WHETHER DEVICE EXPLANTED CONFIRM DEVICE WOULD RETURNED THEREFORE ANALYSIS TESTING DONE EVENTS REPORTED MEDICAL INTERVENTION REQUIRED ALTHOUGH DEVICE-RELATEDNESS ESTABLISHED EVENTS SEROMA GRANULOMATOUS REACTION LIPOPHAGIC NECROSIS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL -- INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION INFLAMMATORY REACTION STUDIES EVALUATING CAPSULES AROUND TEXTURED IMPLANTS REPORTED POSSIBLE SILICONE PARTICLES WITHIN GIANT CELLS INDICATIVE LOCAL NONSPECIFIC FOREIGN BODY REACTION SILICONE GRANULOMA FORMATION CASE INFLAMMATORY REACTION SURGEON ADVISED REMOVE DEVICE PATIENTS BODY SECURE EVIDENCE POSSIBLE CAUSE INFLAMMATORY REACTION TREAT PATIENT CORRESPONDINGLY ADVISED REPLACE IMPLANT INFLAMMATORY REACTION PASSED COMPLETELY CAUSE ELIMINATED NECROSIS NECROSIS MAY INHIBIT WOUND HEALING REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR RESULT NECROSIS USE MICROWAVE DIATHERMY PATIENTS BEAST IMPLANTS MICROWAVE DIATHERMY REPORTED CAUSE TISSUE NECROSIS SKIN EROSION IMPLANT EXTRUSION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRM240|12/10/2015|||DA|N|R||0HP|FTR|1.0|06/17/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2131883|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
4974939|6078051|D|1||HEALTH PROFESSIONAL REPORTS LEFT BREAST GROWTH IMPLANT REMOVED CAPSULE FOUR YEARS LATER ALK NEGATIVE T-CELL LYMPHOMA DIAGNOSED REMOVED CAPSULE SEROMA INVESTIGATED MALIGN CELLS ALK NEGATIVE T-CELL LYMPHOMA CAPTURED LYMPHOMA ADDITIONAL PATHOLOGICAL MARKERS PROVIDED HEALTH PROFESSIONAL ADDITIONALLY NOTED DAMAGE MUST TREATED CHEMOTHERAPY RADIOTHERAPY|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|08/04/2015|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||LA AURORA DE HEREDIA|CS|ALLERGAN|||||||True
4665224|13168503|N|1||DEVICE LABELING ADDRESSES LYMPHOMA LYMPHOMAS INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - DOCUMENTATION MEDICAL SUGGESTS POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSALITY BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXTREMELY RARE OCCURS WOMEN WITHOUT BREAST IMPLANTS DEVICE LABELING ADDRESSES RUPTURE RUPTURE - PTS INFORMED FILLED BREAST IMPLANTS SILICONE GEL LAST LIFETIME IMPLANT RUPTURE POSSIBILITY CONSIDER DECISION REMOVE RUPTURED IMPLANT SUSPECTED TAKEN REVIEWING CLINICAL DATA AVAILABLE CAREFUL THOUGHT PT HOWEVER IMPLANT RUPTURE DIAGNOSED RECOMMENDED REMOVE IMPLANT DEVICE LABELING ADDRESSES LYMPHADENOPATHY ADDITIONAL COMPLICATIONS - BREAST IMPLANT SURGERY FOLLOWING SITUATIONS MAY ARISE PERSIST VARY INTENSITY DURATION PAIN HEMATOMASEROMA CHANGES SENSATION NIPPLE BREAST EXTRUSION NECROSIS DELAYED WOUND HEALING TISSUE ATROPHY BREAST DEFORMITIES CHEST CALCIUM DEPOSITS FORM SOMETIMES CAPSULE TISSUE SURROUNDING IMPLANT MANIFESTED SYMPTOMS PAIN FIRMNESS LYMPHADENOPATHY ALSO REPORTED WOMEN IMPLANTS|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120341|04/06/2015||07/14/2014|DA|Y|Y||0HP|FTR|1.0|12/09/2010|NONE||1178535|||ARKLOW, COUNTY WICKLOW|EI|ALLERGAN|||||||True
4730396|17578076|D|1||JOURNAL ARTICLE ANAPLASTIC LARGE-CELL LYMPHOMA WOMEN BREAST IMPLANTS DEJONG ET AL NOVEMBER 5 2008 JOURNAL AMERICAN MEDICAL ASSOCIATION REPORTS ANAPLASTIC LARGE T-CELL LYMPHOMA DIAGNOSED BILATERALLY STAGE II REPORT DEVICE TEXTURED SILICONE MCGHAN|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|04/24/2015|||DA|N|R||0HP|FTR|1.0||nan||NI|LA AURORA DE HEREDIA|||CS|ALLERGAN|||||||True
6177062|62452555|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA BREAST LUMPS ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6145451|61448260|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED DEVICE RETURN DEVICE RETURNED ANALYSIS PERFORMED RESULTS REPORTED SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY RECORD DHR PERFORMED IDENTIFY DEVIATIONS ERRORS OMISSIONS MANUFACTURING PROCESS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM120-280|12/05/2016||||N|R||0HP|FTR|1.0|06/13/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1287540|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145512|63919660|N|1||B4 DEVICE ANALYZED ALLERGAN B4 VISUAL ANALYSIS RETURNED DEVICE IDENTIFIED BROWN PARTICLES DELAMINATION PLUG STRAP LEAK TEST PERFORMED FOUND LEAKAGE MICROSCOPIC ANALYSIS PERFORMED IDENTIFY DELAMINATION PLUG STRAP DISK SHELL FILL TEST INSPECTION PERFORMED RESULT BLOCKAGE BASED DEVICE ANALYSIS FINAL ASSESSMENT DELAMINATION PLUG STRAP DISK SHELL ASSESSED ADHESIVE FAILURE DEVICE HISTORY RECORD DHR IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS EVENTS LYMPHOMA-ALCL CAPSULAR CONTRACTURE INFLAMMATION PAIN PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA Â¿AS EXPECTED FOLLOWING INVASIVE SURGICAL PROCEDURE PAIN VARYING INTENSITY DURATION MAY OCCUR FOLLOWING IMPLANTATION ADDITION IMPROPER PLACEMENT SURGICAL TECHNIQUE CAPSULAR CONTRACTURE MAY RESULT PAIN ASSOCIATED NERVE ENTRAPMENT INTERFERENCE MUSCLE MOTION UNEXPLAINED PAIN MUST PROMPTLY INVESTIGATEDÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145512|61450145|N|1||DEVICE CURRENTLY RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/03/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013309|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5644586|44853449|N|1||MEDWATCH SENT FDA 05102016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT DEVICE YET RECEIVED DEVICE HISTORY RECORD REVIEWED RESULTS STATE REVIEW DHR B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT SAP VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TSF365|05/10/2016||04/29/2016|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2740658|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6177002|62447626|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5896408|52758840|N|1||MEDWATCH SENT FDA 08232016 DEVICE RETURNED DEVICE ANALYSIS COMPLETE FINDINGS SENT FOLLOW-UP REPORT EVENTS INFLAMMATION LYMPHOMA SWELLING PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING PRODUCT INFORMATION REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|08/23/2016||08/23/2016|DA|R|Y||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||384466|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6106201|60020510|N|1||FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RECEIVED LAB ANALYSIS PERFORMED RESULTS REPORTED SUPPLEMENTAL REPORT EVENTS SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION DEVICE HISTORY RECORD DHR REVIEW SUMMARY REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS ADDITION DHR SHELL RUN NUMBER 8070302 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-MX120-325|11/16/2016||12/14/2016|DA|R|Y||0HP|FTR|1.0|07/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||225212|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5670826|45647376|N|1||REPORTER EVENT ASKED RETURN PRODUCT ANALYSIS ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR WORK ORDER B4 INDICATES REPROCESS PRIMARY PACKAGING OPERATION HOWEVER COMPLETED DIFFERENT SERIAL NUMBER UNIT RELATION NEITHER CAUSE REPORTED EVENT DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER 10009114 10009114 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURANCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MM125-320|05/20/2016|||DA|N|R||0HP|FTR|1.0|02/03/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2073435|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176674|62457390|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA MASS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6142978|61395222|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL DEATH PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153182|61700300|N|1||B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHADENOPATHY LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/07/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5644581|44885546|N|1||EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT KNOWN DEVICE RETURNED MISSING INFORMATION INCLUDES DEVICE SERIAL NUMBER IMPLANT DATE DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL  INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|05/10/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||nan|||||||True
6199283|63133499|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM130-360|12/22/2016|||DA|N|R||0HP|FTR|1.0|11/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||352966|KILBRIDE INDUSTRIAL ESTATE||ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
6023404|57191542|N|1||FOLLOW-UP PERFORMED DEVICE RETURN EVENTS LYMPHOMA SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-FX155-775|10/12/2016||03/02/2017|DA|R|Y||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2379964|900 PARKWAY GLOBAL PARK|ZONA FRANCA|ARKLOW, COUNTY WICKLOW|CS|ALLERGAN|||||||True
5904549|53036936|N|1||MEDWATCH SENT FDA 08252016 RESPONSE FDA REPORT NUMBER MW5063635 B4 DEVICE CONFIRMED AVAILABLE RETURN YET RECEIVED EVENTS LYMPHOMA EDEMA VISIBILITYPALPABILITY SENSATION INCREASE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION SENSATION NIPPLE BREAST INCREASE DECREASE IMPLANT SURGERY TYPICALLY LOST COMPLETE MASTECTOMY NIPPLE REMOVED SEVERELY LESSENED PARTIAL MASTECTOMY|CUI TEXTURED SILICONE GEL FILLED BREAST IMPLANT|MHP-460|08/25/2016||09/29/2016|DA|R|Y||0HP|FTR|1.0|05/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||303203|KILBRIDE INDUSTRIAL ESTATE|ZONA FRANCA|ARKLOW, COUNTY WICKLOW||ALLERGAN|||||||True
5884313|52381106|N|1||FOLLOW-UP POSSIBLE CASE DEVICE HISTORY RECORD REQUESTED DEVICE INFORMATION UNKNOWN DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|08/17/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5595588|43273124|N|1||EVENTS SEROMA-LATE LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLY CAUSE EVENT DEVICE RETURNED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|27-FF140-535|04/21/2016||||N|R||0HP|FTR|1.0|09/15/2007|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||165721|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5896385|52760206|N|1||MEDWATCH SENT FDA 08232016 DEVICE RETURNED DEVICE ANALYSIS COMPLETE FINDINGS SENT FOLLOW-UP REPORT EVENTS INFLAMMATION LYMPHOMA SWELLING PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING PRODUCT INFORMATION REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING ADDRESSES REPORTED EVENTS FOLLOWS LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110241|08/23/2016||08/23/2016|DA|R|Y||0HP|FTR|1.0|02/15/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||384466|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145514|64146442|N|1||B4 DEVICE ANALYZED ALLERGAN B4 VISUAL ANALYSIS RETURNED DEVICE IDENTIFIED FLAT CREASES WHITE PARTICLES DEVICE OUTER SURFACE ONE CURVED OPENING POSTERIOR LEAK TEST PERFORMED IDENTIFIED OPENING MICROSCOPIC ANALYSIS PERFORMED IDENTIFY ONE OPENING STRIATED CURVED ASSESSED SURGICAL DAMAGE PARTIAL DELAMINATION PLUG STRAP DISK SHELL DUE ADHESIVE FAILURE FILL INSPECTION PERFORMED IDENTIFIED BLOCKAGE VALVE BASED DEVICE ANALYSIS FINAL ASSESSMENT ONE OPENING STRIATED CURVED ASSESSED SURGICAL DAMAGE PARTIAL DELAMINATION PLUG STRAP DISK SHELL DUE ADHESIVE FAILURE DEVICE HISTORY RECORD DHR IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS EVENTS LYMPHOMA-ALCL CAPSULAR CONTRACTURE INFLAMMATION PAIN PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST FORMATION FIBROUS TISSUE AROUND IMPLANTED DEVICE NORMAL PHYSIOLOGICAL RESPONSE FIBROUS CAPSULAR CONTRACTURE REMAINS COMMON COMPLICATION FOLLOWING BREAST IMPLANT SURGERY ONE COMMON REASONS REOPERATION CAUSE CAPSULAR CONTRACTURE UNKNOWN HOWEVER LIKELY MULTIFACTORIAL MAY COMMON FOLLOWING INFECTION HAEMATOMA SEROMA CONTRACTURE DEVELOPS VARYING DEGREES UNILATERALLY BILATERALLY MAY OCCUR WITHIN WEEKS YEARS SURGERY CONTRACTURE FIBROUS CAPSULAR TISSUE SURROUNDING IMPLANT MAY CAUSE RANGE SYMPTOMS INCLUDING FIRMNESS DISCOMFORT PAIN DISTORTION PALPABILITY ANDOR DISPLACEMENT SEVERE CASES CONSIDERED CLINICALLY SIGNIFICANT MAY REQUIRE SURGICAL INTERVENTION CAPSULAR CONTRACTURE MAY RECUR SUBSEQUENT CORRECTIVE SURGICAL PROCEDURES TREAT CAPSULAR CONTRACTURE EXTERNAL COMPRESSION MASSAGE MAY RESULT IMPLANT DAMAGE DEFLATION FOLDS ANDOR HAEMATOMA Â¿AS EXPECTED FOLLOWING INVASIVE SURGICAL PROCEDURE PAIN VARYING INTENSITY DURATION MAY OCCUR FOLLOWING IMPLANTATION ADDITION IMPROPER PLACEMENT SURGICAL TECHNIQUE CAPSULAR CONTRACTURE MAY RESULT PAIN ASSOCIATED NERVE ENTRAPMENT INTERFERENCE MUSCLE MOTION UNEXPLAINED PAIN MUST PROMPTLY INVESTIGATEDÂ¿|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6145514|61451047|N|1||DEVICE CURRENTLY RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|STYLE 168 SALINE FILLED BREAST IMPLANT|N-27-168211|12/05/2016||12/16/2016|DA|R|Y||0HP|FWM|1.0|09/09/2015|PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||2013310|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5690994|46271112|N|1||MEDWATCH SENT FDA 06012016 EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT KNOWN DEVICE RETURNED PATIENT INFORMATION PROVIDED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 110 SILICONE GEL FILLED BREAST IMPLANT|27-110391|06/01/2016|||DA|N|R||0HP|FTR|1.0|03/15/2008|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||201218|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5956972|54992702|N|1||EVENTS LYMPHOMA SEROMA-LATE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE RETURNED DISCARDED DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST DEVICE HISTORY RECORD STATES REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS  BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT ORACLE VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUNS NUMBER B4 IDENTIFY ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ERIR NUMBER B4 REFERENCED DHR RECORD SHELL RUN NUMBER B4 ER RELATED TAPERING PROCESS HOWEVER IMPACT DEVICES BASED REGULATORY REQUIREMENTS ERIR NUMBER B4 REFERENCED DHR RECORD SHELL RUN NUMBER B4 ER RELATED TAPERING PROCESS HOWEVER IMPACT DEVICES BASED REGULATORY REQUIREMENTS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS|STYLE 150 EXPANDABLE BREAST IMPLANT|27-150496|09/16/2016|||DA|N|R||0HP|FTR|1.0|02/14/2011|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1205583|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6180550|62543961|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/16/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6177211|62456167|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA LUMP ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176804|62446182|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6148888|61547075|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA PATIENT LI-FRAUMENI SYNDROMEÂ¿ YI-SHAN LEE ARMANDO FILIE DIANE ARTHUR ANTONIO FOJO ELAINE JAFFE PUBLISHED HISTOPATHOLOGY 67 923Â¿935 2015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA CANCER LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/06/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176705|62451142|N|1||B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176730|62445769|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176886|62453116|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA SEROMA MASS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176855|62446706|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6176798|62453768|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6153200|61697779|D|1||LITERATURE ARTICLE Â¿COMPLETE SURGICAL EXCISION ESSENTIAL MANAGEMENT PATIENTS BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMAÂ¿ REPORTS Â¿87 PATIENTS BI-ALCL INCLUDING 50 PREVIOUSLY REPORTED LITERATURE 37 UNREPORTEDÂ¿ ARTICLE CONTINUES STATE Â¿BREAST IMPLANTÂ¿ASSOCIATED ANAPLASTIC LARGE-CELL LYMPHOMA BI-ALCL RARE TYPE T-CELL LYMPHOMA ARISES AROUND BREAST IMPLANTS OPTIMAL MANAGEMENT DISEASE ESTABLISHED GOAL STUDY EVALUATE EFFICACY DIFFERENT THERAPIES USED PATIENTS BI-ALCL DETERMINE OPTIMAL TREATMENT APPROACHÂ¿ Â¿THE MEDIAN MEAN FOLLOW-UP TIMESWERE 45 30 MONTHS RESPECTIVELY RANGE 3 217 MONTHS MEDIAN OVERALL SURVIVAL OS TIME DIAGNOSIS BI-ALCL 13 YEARS OS RATE 93AND 89AT 3 5 YEARS RESPECTIVELY PATIENTS LYMPHOMA CONFINED FIBROUS CAPSULE SURROUNDING IMPLANT BETTER EVENT-FREE SURVIVAL EFS OS PATIENTS LYMPHOMA SPREAD BEYOND CAPSULE P = 03 PATIENTS UNDERWENT COMPLETE SURGICAL EXCISION CONSISTED TOTAL CAPSULECTOMY BREAST IMPLANT REMOVAL BETTER OSP = 022 EFSP = 014 PATIENTS RECEIVED PARTIAL CAPSULECTOMY SYSTEMIC CHEMOTHERAPY RADIATION THERAPYÂ¿ CYTOLOGICAL MARKERS ALK- CD30+ REPORTED CURRENTLY WAY DETERMINE CASES THERAPIES DEVICE TYPE REPORT CAPTURE 37 UNREPORTED CASES ALCL  LYMPHOMA|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/07/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
5488680|39947737|N|1||DEVICE LABELING ADDRESSES LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST STUDIES EVALUATING CAPSULES AROUND TEXTURED EXPANDERS REPORTED POSSIBLE SILICONE PARTICLES GIANT CELLS INDICATIVE LOCAL NON SPECIFIC FOREIGN BODY REACTION SILICONE GRANULOMA FORMATION|STYLE 120 SILICONE GEL FILLED BREAST IMPLANT|27-120301|03/09/2016|||DA|N|R||0HP|FTR|1.0|02/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||276452|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5607727|43625363|N|1||MEDWATCH SENT FDA 04262016 REPORTER EVENT ASKED RETURN PRODUCT ANALYSIS ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|MF-410420|04/26/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5672723|45694207|N|1||MEDWATCH SENT FDA 05232016 REPORTER EVENT IDENTIFIED REGULATORY AGENCY ALLERGAN RECEIVED PRODUCT TIME THEREFORE ANALYSIS TESTING DONE EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTER EVENT IDENTIFIED REGULATORY AGENCY THEREFORE ADDITIONAL INFORMATION AVAILABLE TIME DEVICE HISTORY REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT DEVICES CONFORMANCE MANUFACTURING PROCESS ADDITION DHR SHELL RUN NUMBER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|05/23/2016||||N|R||0HP|FTR|1.0|09/19/2010|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||1139476|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6143087|61396766|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/02/2016|||DA|N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6177272|62460334|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK SALINE IMPLANT|UNK SALINE IMPLANT|12/15/2016||||*|*||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|||||UNK|||||||True
6139636|61290117|N|1||POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED DEVICE RETURNED DEVICE RETURNED ANALYZED RESULTS SENT SUPPLEMENTAL REPORT EVENT HEMATOMA PREVIOUSLY REPORTED VIA RESPONSIVE PSR B6 2016 EVENTS LATE SEROMA LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|INSPIRA TEXTURED SILICONE GEL FILLED BREAST IMPLANT|N-TRLP250|12/01/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2429970|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176870|62452743|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6139164|61260978|N|1||ARTICLE CITATION Â¿MARKED EOSINOPHILIA INITIAL PRESENTATION BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMAÂ¿ NICOLA OROFINO FRANCESCA GUIDOTTI DANIELE CATTANEO MARIARITA SCIUMÃ UMBERTO GIANELLI AGOSTINO CORTELEZZI  ALESSANDRA LURLO PUBLISHED LEUKEMIA  LYMPHOMA PUBLISHED ELECTRONICALLY 17MAR2016 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA-ALCL PRURITUS EOSINOPHILIA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK MAMMARY IMPLANT|UNK MAMMARY IMPLANT|12/01/2016||||N|R||0HP|FWM|1.0||PROSTHESIS, BREAST, INFLATABLE, INTERNAL, SALINE||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6144474|61423058|N|1||ARTICLE CITATION Â¿WHOLE EXOME SEQUENCING REVEALS ACTIVATING JAK1 STAT3 MUTATIONS BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA ANAPLASTIC LARGE CELL LYMPHOMA PIERS BLOMBERY ELLA R THOMPSON KATE JONES GISELA MIR ARNAU STEPHEN LADE JOHN F MARKHAM JASON LI ANAND DEVA RICKY W JOHNSTONE AMIT KHOT H MILES PRINCE DAVID WESTERMAN PUBLISHED HAEMATOLOGICA ELECTRONICALLY PUBLISHED SEPTEMBER 2016 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LATE SEROMA LYMPHOMA-ALCL PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/05/2016||||N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620587|44062744|D|1||EXPLANTING PHYSICIAN REPORTED LEFT SIDE ONSET RECURRENT SEROMAS APPROXIMATELY 10 YEARS IMPLANTATION SEROMAS DRAINED THREE OCCASIONS APPROXIMATELY FOUR MONTHS ONSET SEROMAS AXILLARY MASS APPEARED BIOPSIED DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA ESTABLISHED MULTIPLE ANAPLASTIC CELLS IDENTIFIED SHOWED WEAK CD2 CD3 CD4 EXPRESSION STRONG CD30 TIA-1 PERFORIN EXPRESSION ALK NEGATIVE FINE NEEDLE ASPIRATION BIOPSY REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA DIAGNOSTIC TESTING ADDITIONALLY REVEALED LEFT SIDE LYMPHANGITIS GLOBULAR ADENOPATHIES CAPSULITIS HISTIOCYTES EPITHELIOID ASPECT PART GRANULOMAS PRESENCE LARGE CELLS LARGE AREAS NECROSIS Â¿PERIPROSTHETIC COLLECTIONÂ¿ DIAGNOSTIC TESTING ALSO REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH DIAGNOSIS PATIENT UNDERWENT LEFT SIDE IMPLANT REMOVAL CAPSULECTOMY TOTAL MASTECTOMY LEFT BREAST LIGHT PRESENCE INDURATED BREAST MASS EXTENDING AXILLA PHYSICIAN NOTED IMPLANTS INTACT Â¿THE CAPSULE INTEGRATED TUMOURÂ¿ HISTOLOGIC DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA RETAINED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00036 RIGHT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620587|44062743|N|1||B4 PHYSICIAN NOTED DEVICE LONGER AVAILABLE RETURN THEREFORE ALLERGAN RECEIVE ANALYSIS TESTING DONE REPORTED EVENTS PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION NECROSIS NECROSIS MAY INHIBIT WOUND HEALING REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION PERMANENT SCAR DEFORMITY MAY OCCUR RESULT NECROSIS USE MICROWAVE DIATHERMY PATIENTS BREAST IMPLANTS MICROWAVE DIATHERMY REPORTED CAUSE TISSUE NECROSIS SKIN EROSION IMPLANT EXTRUSION|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
5620587|49100603|D|1||EXPLANTING PHYSICIAN REPORTED LEFT SIDE ONSET RECURRENT SEROMAS APPROXIMATELY 10 YEARS IMPLANTATION SEROMAS DRAINED THREE OCCASIONS APPROXIMATELY FOUR MONTHS ONSET SEROMAS AXILLARY MASS APPEARED BIOPSIED DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA ESTABLISHED MULTIPLE ANAPLASTIC CELLS IDENTIFIED SHOWED WEAK CD2 CD3 CD4 EXPRESSION STRONG CD30 TIA-1 PERFORIN EXPRESSION ALK NEGATIVE FINE NEEDLE ASPIRATION BIOPSY REVEALED FOLLOWING ADDITIONAL DIAGNOSIS CYTOLOGIC FINDINGS COMPATIBLE LYMPH NODE INVOLVEMENT LYMPHOPROLIFERATIVE PROCESS CD30-POSITIVE PROBABLY HODGKINS LYMPHOMA DIAGNOSTIC TESTING ADDITIONALLY REVEALED LEFT SIDE LYMPHANGITIS GLOBULAR ADENOPATHIES CAPSULITIS HISTIOCYTES EPITHELIOID ASPECT PART GRANULOMAS PRESENCE LARGE CELLS LARGE AREAS NECROSIS Â¿PERIPOSTHETIC COLLECTIONÂ¿ DIAGNOSTIC TESTING ALSO REVEALED NON SIDE-SPECIFIC EVENTS GOITER Â¿LUNG PARENCHYMA MODERATE PARASEPTAL CENTRILOLOBULAR EMPHYSEMA MIDDLE UPPER FIELDSÂ¿ Â¿LAMINAR ATELECTASISÂ¿ APPROXIMATELY ONE MONTH DIAGNOSIS PATIENT UNDERWENT LEFT SIDE IMPLANT REMOVAL CAPSULECTOMY TOTAL MASTECTOMY LEFT BREAST LIGHT PRESENCE INDURATED BREAST MASS EXTENDING AXILLA PHYSICIAN NOTED IMPLANTS INTACT Â¿THE CAPSULE INTEGRATED TUMOURÂ¿ HISTOLOGIC DIAGNOSIS ANAPLASTIC T-CELL LYMPHOMA RETAINED PHYSICIAN NOTED SURGERY OBSERVED CLINICAL WORSENING PATIENT RESPIRATORY FAILURE SECONDARY LEFT PLEURAL EFFUSION RESULTING ADMISSION ICU THORACIC DRAINAGE RECURRENT CHEST TUBE DRAINAGE REQUIRED 3 OCCASIONS PATIENTS FIRST STAY ICU PATIENT GOES FIRST FLOOR RECEIVES FIRST CYCLE CHEMOTHERAPY SHOWING GRADE IV NEUTROPENIA DIARRHOEA SECOND CHEMOTHERAPY PATIENT SHOWS MARKED CLINICAL DETERIORATION SUSPICIOUS TUMOUR LYSIS SYNDROME METABOLIC ACIDOSIS RENAL FAILURE RESULTS SECOND ADMISSION ICU PATIENT DIED APPROXIMATELY FIVE WEEKS IMPLANT REMOVAL MEDWATCH REPRESENTS LEFT SIDE SEE MFR  9617229-2016-00036 RIGHT SIDE|STYLE 410 SILICONE GEL FILLED BREAST IMPLANT|ST-MM125-320|04/29/2016|||DA|N|R||0HP|FTR|1.0|06/15/2009|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||306845|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176830|62457610|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167285|62187249|N|1||Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6143032|61396906|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LATE SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/02/2016|||DA|N|R||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6167248|62147366|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA ALCL LATE SEROMA LUMPNODULE PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANATION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/12/2016|||DA|*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
5695364|46431598|N|1||MEDWATCH SENT FDA 06022016 SEROMA RUPTURE INITIALLY SUBMITTED FDA VIA 410 PSR 01212016 DEVICE FOUND INTACT RUPTURE OCCUR EVENT LYMPHOMA PHYSIOLOGICAL COMPLICATION ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT PHYSICIAN CONFIRMED DEVICE RETURNED PHYSICIAN RESPONDED FOLLOW-UP ATTEMPTS COMPLETION ALCL QUESTIONNAIRE PATHOLOGY REPORTS DEVICE HISTORY REVIEW REVIEW DHR WORK ORDER B4 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES MANUFACTURING PROCESS GEL BREAST IMPLANTS REVIEWED PART ASSEMBLY OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE ASSEMBLY MET REQUIRED SPECIFICATIONS DHR ASSEMBLY REPORT VERIFIED SCRAP RELATED REPORTED EVENT ONE DEVICE SCRAPPED ADDITION DHR SHELL RUNS NUMBER 10008414 10008555 IDENTIFY DEVIATIONS ERRORS OMISSIONS NON-CONFORMANCES SHELL FABRICATION PROCESS SHELLS REVIEWED PART SHELL FABRICATION OPERATIONS TASKS PERFORMED ACCORDING APPLICABLE CURRENT PROCEDURES ENSURE FABRICATION MET REQUIRED SPECIFICATIONS ACCORDING INFORMATION GATHERED DHR REVIEW ENOUGH EVIDENCE SUPPORT DEVICES WORK ORDER B4 ASSEMBLED ACCORDANCE ALLERGAN MEDICAL PROCEDURES SPECIFICATIONS REPORTED DEVICE INTACT TIME PRODUCTION MET REQUIRED SPECIFICATIONS DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMA ALCL Â¿ INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST|STYLE 410 COHESIVE SILICONE GEL FILLED BREAST IMPLANT|N-27-MX135-445|06/02/2016||||N|R||0HP|FTR|1.0|01/24/2016|PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||2070807|900 PARKWAY GLOBAL PARK|ZONA FRANCA||CS|ALLERGAN|||||||True
6176648|62440609|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 B4 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS DEATH LYMPHOMA ALCL SEROMA LUMP ERYTHEMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENT INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION ERYTHEMA MAY ALSO OCCUR NORMAL RESPONSE EXPANSION|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
6176965|62446267|N|1||ARTICLE CITATION Â¿BREAST IMPLANT-ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA TWO DISTINCT CLINICOPATHOLOGICAL VARIANTS DIFFERENT OUTCOMESÂ¿ C LAURENT DELAS P GAULARD C HAIOUN MOREAU L XERRI TRAVERSE-GLEHEN ROUSSET QUINTIN-ROUE PETRELLA J F EMILE N AMARA P ROCHAIX P CHENARD-NEU TASEI E MENET H CHOMARAT V COSTES L ANDRAC-MEYER J F MICHIELS C CHASSAGNE-CLEMENT L DE LEVAL P BROUSSET G DELSOL  L LAMANT PUBLISHED ANNALS ONCOLOGY ELECTRONICALLY PUBLISHED 11232015 POSSIBLE FULLY INVESTIGATE CONFIRM ALLEGED EVENT PRODUCT RETURNED ALLERGAN ANALYSIS FOLLOW-UP PERFORMED REQUEST DEVICE RETURN DEVICE RETURNED ANALYZED RESULTS SENT FDA SUPPLEMENTAL REPORT EVENTS LYMPHOMA-ALCL SEROMA PHYSIOLOGICAL COMPLICATIONS ANALYSIS DEVICE GENERALLY ASSIST ALLERGAN DETERMINING PROBABLE CAUSE EVENTS INFORMATION REPORTER REGARDING EVENT PRODUCT PATIENT DETAILS REQUESTED ADDITIONAL INFORMATION AVAILABLE TIME REPORTED EVENTS ADDRESSED DEVICE LABELING LYMPHOMA INCLUDING ANAPLASTIC LARGE T-CELL LYMPHOMAALCL - INFORMATION MEDICAL LITERATURE SUGGESTED POSSIBLE ASSOCIATION WITHOUT EVIDENCE CAUSATION BREAST IMPLANTS RARE OCCURRENCE ALCL BREAST DISEASE EXCEPTIONALLY RARE MAY PRESENT LATE OCCURRING PERI-PROSTHETIC SEROMA OCCURS WOMEN WITHOUT BREAST IMPLANTS SPECIFIC TESTING NEEDED DISTINGUISH ALCL BREAST CANCER MAJORITY REPORTED CASES INDOLENT CLINICAL COURSE FOLLOWING CAPSULECTOMY WITHOUT ADJUVANT THERAPY GENERALLY UNCHARACTERISTIC SYSTEMIC ALCL TREATMENT DETERMINED CONSULTATION HEMATO-ONCOLOGIST HAEMATOMASEROMA MAY OCCUR POSTOPERATIVE PERIOD INHIBITING WOUND HEALING DELAYED ONSET EITHER MAY REQUIRE SURGICAL CORRECTION ANDOR EXPLANTATION GEL IMPLANTS MAY RUPTURE SALINE GELSALINE IMPLANTS MAY DEFLATE TIME REQUIRE REPLACEMENT REVISION SURGERY RUPTURES OFTEN CLINICALLY SILENT RADIOLOGICAL ASSESSMENT MAY REQUIRED AID DIAGNOSIS|UNK GEL BREAST IMPLANT|UNK GEL BREAST IMPLANT|12/15/2016||||*|*||0HP|FTR|1.0||PROSTHESIS, BREAST, NONINFLATABLE, INTERNAL, SILICONE GEL-FILLED||NI|||||UNK|||||||True
